Current status of esophageal cancer treatment

Tania Triantafyllou, Bas P L Wijnhoven

2020, 32(3): 271-286. doi: 10.21147/j.issn.1000-9604.2020.03.01

Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives

Zhening Zhang, Tong Xie, Xiaotian Zhang, Changsong Qi, Lin Shen, Zhi Peng

2020, 32(3): 287-302. doi: 10.21147/j.issn.1000-9604.2020.03.02

Immune checkpoint inhibitors in malignant lymphoma: Advances and perspectives

Ningjing Lin, Yuqin Song, Jun Zhu

2020, 32(3): 303-318. doi: 10.21147/j.issn.1000-9604.2020.03.03

Impact of enteroscopy on diagnosis and management of small bowel tumors

Adriana Vaz Safatle-Ribeiro, Ulysses Ribeiro Jr.

2020, 32(3): 319-333. doi: 10.21147/j.issn.1000-9604.2020.03.04

Low-depth whole genome sequencing reveals copy number variations associated with higher pathologic grading and more aggressive subtypes of lung non-mucinous adenocarcinoma

Zheng Wang, Lin Zhang, Lei He, Di Cui, Chenglong Liu, Liangyu Yin, Min Zhang, Lei Jiang, Yuyan Gong, Wang Wu, Bi Liu, Xiaoyu Li, David S Cram, Dongge Liu

2020, 32(3): 334-346. doi: 10.21147/j.issn.1000-9604.2020.03.05

Adipocyte-derived SFRP5 inhibits breast cancer cells migration and invasion through Wnt and epithelial-mesenchymal transition signaling pathways

Wenzhong Zhou, Chunmiao Ye, Liang Li, Liyuan Liu, Fei Wang, Lixiang Yu, Fei Zhou, Yujuan Xiang, Yongjiu Wang, Gengshen Yin, Zhongbing Ma, Qinye Fu, Qiang Zhang, Dezong Gao, Shuya Huang, Zhigang Yu

2020, 32(3): 347-360. doi: 10.21147/j.issn.1000-9604.2020.03.06

Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study

Wei Zhao, Li Bian, Tao Wang, Shaohua Zhang, Jianbin Li, Fengrui Xu, Zefei Jiang

2020, 32(3): 361-369. doi: 10.21147/j.issn.1000-9604.2020.03.07

Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors

Huiping Li, Rongrui Liu, Bin Shao, Ran Ran, Guohong Song, Ke Wang, Yehui Shi, Jihong Liu, Wenjing Hu, Fu Chen, Xiaoran Liu, Gairong Zhang, Chuanhua Zhao, Ru Jia, Quanren Wang, Hope S. Rugo, Yifan Zhang, Guangze Li, Jianming Xu

2020, 32(3): 370-382. doi: 10.21147/j.issn.1000-9604.2020.03.08

Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies

Yuqian Zhao, Fanghui Zhao, Shangying Hu, Xun Zhang, Wenhua Zhang, Qinjing Pan, Julia C Gage, Rengaswamy Sankaranarayanan, Youlin Qiao

2020, 32(3): 383-394. doi: 10.21147/j.issn.1000-9604.2020.03.09

Clinical and functional comparison of dynamic hip screws and intramedullary nails for treating proximal femur metastases in older individuals

Hua Gao, Xiaodong Bai, Wentao Chen, Yadong Li, Liang Zhao, Changgui Liu, Zhenyu Liu, Baojun Wang

2020, 32(3): 395-402. doi: 10.21147/j.issn.1000-9604.2020.03.10

Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019

Shanshan Weng, Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

2020, 32(3): 403-407. doi: 10.21147/j.issn.1000-9604.2020.03.11

An organoids biobank for recapitulating tumor heterogeneity and personalized medicine

Hui Yang, Ning Zhang, Yu-Cun Liu

2020, 32(3): 408-413. doi: 10.21147/j.issn.1000-9604.2020.03.12

Corrigendum to Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing

2020, 32(3): 414-. doi: 10.21147/j.issn.1000-9604.2020.03.13